BTP9-Neu5Ac is an imaging probe to visualize location of sialidase activity.

Newly synthesized NAs after influenza A virus infection are localized at the Golgi.

Our BTP9-Neu5Ac-based protocol can visualize activity of the Golgi-localized NA.

Laninamivir octanoate inhibits sialidase activity of the Golgi-localized viral NA.

In influenza A virus-infected cells, newly synthesized viral neuraminidases (NAs) transiently localize at the host cell Golgi due to glycosylation, before their expression on the cell surface. It remains unproven whether Golgi-localized intracellular NAs exhibit sialidase activity. We have developed a sialidase imaging probe, [2-(benzothiazol-2-yl)−5-(non-1-yn-1-yl) phenyl]-α-D-N-acetylneuraminic acid (BTP9-Neu5Ac). This probe is designed to be cleaved by sialidase activity, resulting in the release of a hydrophobic fluorescent compound, 2-(benzothiazol-2-yl)−5-(non-1-yn-1-yl) phenol (BTP9). BTP9-Neu5Ac makes the location of sialidase activity visually detectable by the BTP9 fluorescence that results from the action of sialidase activity. In this study, we established a protocol to visualize the sialidase activity of intracellular NA at the Golgi of influenza A virus-infected cells using BTP9-Neu5Ac. Furthermore, we employed this fluorescence imaging protocol to elucidate the intracellular inhibition of laninamivir octanoate, an anti-influenza drug. At approximately 7 h after infection, newly synthesized viral NAs localized at the Golgi. Using our developed protocol, we successfully histochemically stained the sialidase activity of intracellular viral NAs localized at the Golgi. Importantly, we observed that laninamivir octanoate effectively inhibited the intracellular viral NA, in contrast to drugs like zanamivir or laninamivir. Our study establishes a visualization protocol for intracellular viral NA sialidase activity and visualizes the inhibitory effect of laninamivir octanoate on Golgi-localized intracellular viral NA in infected cells.

Fluorescence probe

Imaging

Influenza virus

Neuraminidase

Sialidase

2-(benzothiazol-2-yl)−4-bromophenyl-α-D-N-acetylneuraminic acid

[2-(benzothiazol-2-yl)−5-(non-1-yn-1-yl) phenyl]-α-D-N-acetylneuraminic acid

4',6-diamidino-2-phenylindole

Eagle’s minimum essential medium

N-acetylneuraminic acid

phosphate-buffered saline

© 2023 The Author(s). Published by Elsevier B.V.